Price | 599€+ Login to see price |
Organism | Human |
Product Type | Next Generation Sequencing(NGS) analaysis services |
Tissue | – |
Disease | – |
Applications
Technology Service
Next-Generation Sequencing (NGS)
With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...
Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...
Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...
We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...
Next-Generation Sequencing (NGS) is a rapid and efficient DNA sequencing technology used for analyzing multiple samples in bulk.
Widely applied in genomics, transcriptomics, and personalized medicine, NGS offers fast and accurate results.
At LAMBDA’s NGS center, our team of specialists utilizes the latest analytical technologies and extensive experience to deliver results that closely align with researchers’ objectives.
We are dedicated to providing rapid and accurate results tailored to our customers’ research needs.
Wes provides Whole Exome Sequencing (WES) to comprehensively identify genetic variations, particularly useful for diverse of cells and tissues and especially Organoid Quality Control. We ensure the accuracy, reliability, and suitability for various research applications.
Lambda Biologics GmbH
Deutscher Platz 5 c, 04103, Leipzig, Germany
info@lambdabiologics.com
